Marcus Lacerda

机构：Fundação de Medicina Tropical, Universidade do Estado do Amazonas, Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais, Fundação Oswaldo Cruz, The University of Texas Medical Branch at Galveston · ORCID：0000-0003-3374-9985

发表论文 648 篇 · 总被引 21417 次 · h-index 70

代表论文

• Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study (2025 · Clinical Infectious Diseases · 被引 9)
• Clinical and laboratory profiles of Oropouche virus disease from the 2024 outbreak in Manaus, Brazilian Amazon (2025 · PLoS neglected tropical diseases · 被引 7)
• Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil (2025 · The Lancet Infectious Diseases · 被引 5)
• Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria (2025 · Blood Advances · 被引 4)
• IDO1-AhR axis increases T regulatory cells in Plasmodium vivax malaria infection (2025 · Frontiers in Immunology · 被引 4)
• Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon (2025 · Scientific Reports · 被引 4)